Once a prescription is written – just one part of the brand adoption challenge – pharmaceutical manufacturers are limited in their ability to influence patient compliance and persistence. For years, pharma manufacturers have struggled to influence change in the 20-30 percent of prescriptions that never get filled and the estimated 50 percent of patients who… read more
From Washington, DC to your clinic’s front door: what will we learn together at the 2018 340B Coalition Winter Conference?
Now more than ever, 340B covered entities must ensure they are providing high value, critical care for underserved populations in a way that stands up to scrutiny. What will we learn at 340B Winter 2018?
What pharma can’t say about outcomes based contracts at JPMorgan 2018. Hint: It’s the “P” word.
Here’s a hint: It’s mostly about why ACO leadership should attend FLAACOs 2018. CMS recently reported that more than 400 ACOs participating in the Medicare Shared Savings Program generated $652 million in gross savings in 2016. While that is an encouraging number to be sure, some ACOs still struggle to identify and implement investment and… read more
By definition, accountable care organizations are the tip of the spear in the transition from fee-for-service to value-based care by tying payments to quality metrics and the cost of care. Did you know there are 16 quality performance standards by which ACOs are evaluated tied to medication adherence, education and the medication management team? Through… read more
Video: Positively impacting outcomes through pharmacist-led chronic care management for IBD patients. Johns Hopkins Medicine and Curant Health are in the midst of a unique, 24-month project examining the impact of medication adherence and chronic care management for IBD patients. This ‘first of its kind’ pilot examines adherence impacts for all medications, not just one… read more
Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or email@example.com